Saffron for the management of premenstrual dysphoric disorder: A randomized controlled trial

Background: Selective serotonin reuptake inhibitors are among the most common agents have been used for the treatment of the premenstrual dysphoric disorder (PMDD); however, due to the diversity in the outcomes and adverse effects, efforts are in progress to find an agent with maximal efficacy and m...

Full description

Bibliographic Details
Main Authors: Fatemeh Rajabi, Marjan Rahimi, Mohammad Reza Sharbafchizadeh, Mohammad Javad Tarrahi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2020;volume=9;issue=1;spage=60;epage=60;aulast=Rajabi